We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Central Pacific Financial
CPF
$1.02B
| $607K | ﹤0.01% |
33,900
+5,700
| +20% | +$121K |
|
1227
Vistra
VST
$52.6B
| $603K | ﹤0.01% |
25,135
-1,600
| -6% | -$37.1K |
|
1228
Xometry
XMTR
$4.81B
| $597K | ﹤0.01% |
39,856
-3,000
| -7% | -$78.9K |
|
1229
Fulgent Genetics
FLGT
$500M
| $587K | ﹤0.01% |
18,800
| – | – |
|
1230
Fortune Brands Innovations
FBIN
$6.22B
| $585K | ﹤0.01% |
9,963
-29,823
| -75% | -$1.82M |
|
|
SFBS
1231
ServisFirst Bancshares
SFBS
$4.92B
| $583K | ﹤0.01% |
10,669
-1,235
| -10% | -$82.8K |
|
1232
LegalZoom.com
LZ
$1.42B
| $581K | ﹤0.01% |
61,906
| – | – |
|
1233
Clearwater Paper
CLW
$359M
| $575K | ﹤0.01% |
17,200
+6,700
| +64% | +$242K |
|
1234
Dynatrace
DT
$12.9B
| $574K | ﹤0.01% |
13,579
+1,300
| +11% | +$52.6K |
|
1235
Alcoa
AA
$11.8B
| $572K | ﹤0.01% |
13,449
-400
| -3% | -$19.3K |
|
1236
Myers Industries
MYE
$1.38B
| $570K | ﹤0.01% |
+26,600
| New | +$605K |
|
1237
Compass Minerals
CMP
$1.21B
| $569K | ﹤0.01% |
+16,600
| New | +$664K |
|
|
SVM
1238
Silvercorp Metals
SVM
$2.11B
| $564K | ﹤0.01% |
148,622
+11,518
| +8% | +$37.9K |
|
|
MOR
1239
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $562K | ﹤0.01% |
142,268
| – | – |
|
1240
Arrow Electronics
ARW
$11.1B
| $560K | ﹤0.01% |
4,484
-170
| -4% | -$20.2K |
|
1241
Hain Celestial
HAIN
$45.5M
| $549K | ﹤0.01% |
32,034
-933
| -3% | -$17K |
|
1242
HF Sinclair
DINO
$15.8B
| $548K | ﹤0.01% |
11,336
-1,100
| -9% | -$57.2K |
|
1243
Regal Rexnord
RRX
$14.1B
| $548K | ﹤0.01% |
3,892
-154
| -4% | -$22.3K |
|
1244
Quanex
NX
$883M
| $547K | ﹤0.01% |
25,400
+16,900
| +199% | +$406K |
|
1245
UGI
UGI
$7.78B
| $546K | ﹤0.01% |
15,710
-100
| -0.6% | -$3.79K |
|
|
BRKL
1246
DELISTED
Brookline Bancorp
BRKL
| $545K | ﹤0.01% |
51,900
-20,500
| -28% | -$258K |
|
1247
Lennox International
LII
$15B
| $543K | ﹤0.01% |
2,162
+38
| +2% | +$9.59K |
|
1248
S&T Bancorp
STBA
$1.85B
| $538K | ﹤0.01% |
17,100
| – | – |
|
|
TBI
1249
Trueblue
TBI
$229M
| $538K | ﹤0.01% |
+30,200
| New | +$565K |
|
1250
Vanguard FTSE Europe ETF
VGK
$30.8B
| $536K | ﹤0.01% |
+8,800
| New | +$526K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.